User menu

Overview of magnetic resonance imaging for management of relapsing-remitting multiple sclerosis in everyday practice.

Bibliographic reference Oreja-Guevara, Celia ; ParadigMS Group ; Van Pesch, Vincent. Overview of magnetic resonance imaging for management of relapsing-remitting multiple sclerosis in everyday practice.. In: European Journal of Neurology, Vol. 22, no. 2, p. 22-27 (2015)
Permanent URL http://hdl.handle.net/2078.1/172048
  1. Barkhof Frederik, The clinico-radiological paradox in multiple sclerosis revisited : , 10.1097/00019052-200206000-00003
  2. Oreja-Guevara Celia, Charil Arnaud, Caputo Domenico, Cavarretta Rosella, Sormani Maria Pia, Filippi Massimo, Magnetization Transfer Magnetic Resonance Imaging and Clinical Changes in Patients With Relapsing-Remitting Multiple Sclerosis, 10.1001/archneur.63.5.736
  3. Sicotte Nancy L., Neuroimaging in Multiple Sclerosis: Neurotherapeutic Implications, 10.1007/s13311-010-0008-y
  4. Simon Jack H., MRI outcomes in the diagnosis and disease course of multiple sclerosis, Handbook of Clinical Neurology (2014) ISBN:9780444520012 p.405-425, 10.1016/b978-0-444-52001-2.00017-0
  5. Arnold, Int MS J, 17, 58 (2011)
  6. Geurts Jeroen JG, Calabrese Massimiliano, Fisher Elizabeth, Rudick Richard A, Measurement and clinical effect of grey matter pathology in multiple sclerosis, 10.1016/s1474-4422(12)70230-2
  7. Naismith R. T., Piccio L., Lyons J. A., Lauber J., Tutlam N. T., Parks B. J., Trinkaus K., Song S. K., Cross A. H., Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: A 52-week phase II trial, 10.1212/wnl.0b013e3181e24373
  8. Kappos Ludwig, Antel Jack, Comi Giancarlo, Montalban Xavier, O'Connor Paul, Polman Chris H., Haas Tomas, Korn Alexander A., Karlsson Goeril, Radue Ernst W., Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis, 10.1056/nejmoa052643
  9. Sicotte Nancy L., Magnetic Resonance Imaging in Multiple Sclerosis: The Role of Conventional Imaging, 10.1016/j.ncl.2011.01.005
  10. Tillema Jan-Mendelt, Pirko Istvan, Neuroradiological evaluation of demyelinating disease, 10.1177/1756285613478870
  11. Rovira A., Tintoré M., Álvarez-Cermeño J.C., Izquierdo G., Prieto J.M., Recomendaciones para la utilización e interpretación de los estudios de resonancia magnética en la esclerosis múltiple, 10.1016/j.nrl.2010.03.001
  12. Filippi Massimo, Rocca Maria A., Bastianello Stefano, Comi Giancarlo, Gallo Paolo, Gallucci Massimo, Ghezzi Angelo, Marrosu Maria Giovanna, Minonzio Giorgio, Pantano Patrizia, Pozzilli Carlo, Tedeschi Gioacchino, Trojano Maria, Falini Andrea, De Stefano Nicola, Guidelines from The Italian Neurological and Neuroradiological Societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patients, 10.1007/s10072-013-1485-7
  13. Polman Chris H., Reingold Stephen C., Banwell Brenda, Clanet Michel, Cohen Jeffrey A., Filippi Massimo, Fujihara Kazuo, Havrdova Eva, Hutchinson Michael, Kappos Ludwig, Lublin Fred D., Montalban Xavier, O'Connor Paul, Sandberg-Wollheim Magnhild, Thompson Alan J., Waubant Emmanuelle, Weinshenker Brian, Wolinsky Jerry S., Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria, 10.1002/ana.22366
  14. Wattjes, AJNR Am J Neuroradiol, 28, 54 (2007)
  15. Polman Chris H., Reingold Stephen C., Edan Gilles, Filippi Massimo, Hartung Hans-Peter, Kappos Ludwig, Lublin Fred D., Metz Luanne M., McFarland Henry F., O'Connor Paul W., Sandberg-Wollheim Magnhild, Thompson Alan J., Weinshenker Brian G., Wolinsky Jerry S., Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”, 10.1002/ana.20703
  16. Simon, AJNR Am J Neuroradiol, 27, 455 (2006)
  17. Barkhof Frederik, Simon Jack H., Fazekas Franz, Rovaris Marco, Kappos Ludwig, de Stefano Nicola, Polman Chris H., Petkau John, Radue Ernst W., Sormani Maria P., Li David K., O'Connor Paul, Montalban Xavier, Miller David H., Filippi Massimo, MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials, 10.1038/nrneurol.2011.190
  18. Sormani Maria Pia, De Stefano Nicola, Defining and scoring response to IFN-β in multiple sclerosis, 10.1038/nrneurol.2013.146
  19. Lavery, Mult Scler Int, 2014, 262350 (2014)
  20. Río J, Rovira À, Tintoré M, Huerga E, Nos C, Tellez N, Tur C, Comabella M, Montalban X, Relationship between MRI lesion activity and response to IFN-β in relapsing–remitting multiple sclerosis patients, 10.1177/1352458507085555
  21. Río Jordi, Comabella Manuel, Montalban Xavier, Predicting responders to therapies for multiple sclerosis, 10.1038/nrneurol.2009.139
  22. Río J, Castilló J, Rovira A, Tintoré M, Sastre-Garriga J, Horga A, Nos C, Comabella M, Aymerich X, Montalbán X, Measures in the first year of therapy predict the response to interferon β in MS, 10.1177/1352458509104591
  23. Dong-Si T Richman S Bloomgren G et al Survival and functional outcome in asymptomatic natalizumab-associated progressive multifocal leukoencephalopathy multiple sclerosis patients
  24. Freedman Mark S., Patry David G., Grand'Maison François, Myles Mary Lou, Paty Donald W., Selchen Daniel H., Treatment Optimization in Multiple Sclerosis, 10.1017/s0317167100053804
  25. Freedman Mark S., Selchen Daniel, Arnold Douglas L., Prat Alexandre, Banwell Brenda, Yeung Michael, Morgenthau David, Lapierre Yves, Treatment Optimization in MS: Canadian MS Working Group Updated Recommendations, 10.1017/s0317167100014244
  26. Sormani MP, Rio J, Tintorè M, Signori A, Li D, Cornelisse P, Stubinski B, Stromillo ML, Montalban X, De Stefano N, Scoring treatment response in patients with relapsing multiple sclerosis, 10.1177/1352458512460605